Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice

Authors: Li D, Bian L, Cui L, Zhou J, Li G, Zhao X, Xing L, Cui J, Sun B, Jiang C, Kong W, Zhang Y, Chen Y

Source: International Journal of Nanomedicine, Vol Volume 19, Pp 8029-8042 (2024)

Subject Terms: varicella-zoster virus, mrna vaccine, glycoprotein e, lipid nanoparticles, heterologous prime-boost, cell-mediated immunity, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.dovepress.com/heterologous-prime-boost-immunization-strategies-using-varicella-zoste-peer-reviewed-fulltext-article-IJN; https://doaj.org/toc/1178-2013

Access URL: https://doaj.org/article/07528551113b4c769cc33f13f20543bb

Mucosal adjuvanticity and mucosal booster effect of colibactin-depleted probiotic Escherichia coli membrane vesicles

Authors: Hiroki Uchiyama, Toshifumi Kudo, Takehiro Yamaguchi, Nozomu Obana, Kenji Watanabe, Kimihiro Abe, Hidetaka Miyazaki, Masanori Toyofuku, Nobuhiko Nomura, Yukihiro Akeda, Ryoma Nakao

Source: Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)

Subject Terms: Administration route, mucosal adjuvanticity, immunogenicity, heterologous prime-boost immunization, respiratory tract infection, Streptococcus pneumoniae, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/f9ac0a5cea9a47029ede47ea185d23ea

Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study

Authors: Szu-Ting Huang, Yu-Shan Huang, Wang-Da Liu, Sung-Ching Pan, Hsin-Yun Sun, Chia-En Lien, Charles Chen, Szu-Min Hsieh

Source: Journal of the Formosan Medical Association, Vol 122, Iss 11, Pp 1165-1173 (2023)

Subject Terms: COVID-19, Heterologous prime boost, mRNA vaccine, Protein-based vaccine, Immunogenicity, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S0929664623001997; https://doaj.org/toc/0929-6646

Access URL: https://doaj.org/article/eeee38274f504e0eacc3fd5a4dcf4840

Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study

Authors: Niko Kohmer, Shivana Stein, Barbara Schenk, Katharina Grikscheit, Melinda Metzler, Holger F. Rabenau, Marek Widera, Eva Herrmann, Sabine Wicker, Sandra Ciesek

Source: International Journal of Infectious Diseases, Vol 128, Iss , Pp 166-175 (2023)

Subject Terms: Heterologous prime-boost, ChAdOx1-S, BNT162b2, Immunogenicity, Reactogenicity, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1201971222006725; https://doaj.org/toc/1201-9712

Access URL: https://doaj.org/article/71587574b93e4fd791db7567f3c3fe3d

Heterologous prime-boost vaccine using antigen-loaded microparticles and adenovirus (encoding antigen) enhances cellular immune responses and antitumor activity

Authors: Ellis, Alexis A. ^a, Geary, Sean M. ^{a, ⁎}, Salem, Aliasger K. ^{a, ⁎}

Source: In International Journal of Pharmaceutics 10 May 2023 638

Mouse study of combined DNA/protein COVID-19 vaccine to boost high levels of antibody and cell mediated immune responses

Authors: Qian He, Shuying Liu, Zhenglun Liang, Shan Lu, Wei Cun, Qunying Mao

Source: Emerging Microbes and Infections, Vol 12, Iss 1 (2023)

Subject Terms: SARS-CoV-2, DNA vaccine, protein vaccine, heterologous prime – boost, antibody, T cells, Infectious and parasitic diseases, RC109-216, Microbiology, QR1-502

File Description: electronic resource

Relation: https://doaj.org/toc/2222-1751

Access URL: https://doaj.org/article/bad3e020a0af4ba5821ea92217e0ddc8

Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model

Authors: Vasilis C. Pliasas, Peter J. Neasham, Maria C. Naskou, Rachel Neto, Philip G. Strate, J. Fletcher North, Stephen Pedroza, Strickland D. Chastain, Ian Padykula, S. Mark Tompkins, Constantinos S. Kyriakis

Source: Frontiers in Immunology, Vol 14 (2023)

Subject Terms: influenza A virus, vaccine, swine, hemagglutinin, heterologous prime-boost, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1253626/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/63c844d27d8246f6856e46142c485992

Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial

Authors: Leyla Sharifi Aliabadi, Manoochehr Karami, Maryam Barkhordar, Seyed Saeed Hashemi Nazari, Amir Kavousi, Mohammad Ahmadvand, Mohammad Vaezi

Source: Frontiers in Immunology, Vol 14 (2023)

Subject Terms: SARS-CoV-2, heterologous prime boost COVID-19 vaccination, hematopoietic stem cell transplantation, RBD subunit vaccine, inactivated vaccines, immunogenicity, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1237916/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/c4d580ed5ea7477ca3d3f356d5f6a89e

Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review

Authors: Ishan Garg, Abu Baker Sheikh, Suman Pal, Rahul Shekhar

Source: Infectious Disease Reports, Vol 14, Iss 4, Pp 537-546 (2022)

Subject Terms: COVID-19, COVID-19 vaccine, booster, heterologous prime-boost, mix-and-match, Other systems of medicine, RZ201-999

File Description: electronic resource

Relation: https://www.mdpi.com/2036-7449/14/4/57; https://doaj.org/toc/2036-7449

Access URL: https://doaj.org/article/0f94c95255014b5a822c4d128ad0ef2b

Alternating 3 different influenza vaccines for swine in Europe for a broader antibody response and protection

Authors: Anna Parys, Elien Vandoorn, Koen Chiers, Kristien Van Reeth

Source: Veterinary Research, Vol 53, Iss 1, Pp 1-15 (2022)

Subject Terms: Influenza A virus, swine, vaccination, heterologous prime-boost, antibody cross-reactivity, efficacy, Veterinary medicine, SF600-1100

File Description: electronic resource

Relation: https://doaj.org/toc/1297-9716

Access URL: https://doaj.org/article/d8db9626f77b4b77b1f7eff3bfa0111c

Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice

Authors: Xingxing Li, Jingjing Liu, Wenjuan Li, Qinhua Peng, Miao Li, Zhifang Ying, Zelun Zhang, Xinyu Liu, Xiaohong Wu, Danhua Zhao, Lihong Yang, Shouchun Cao, Yanqiu Huang, Leitai Shi, Hongshan Xu, Yunpeng Wang, Guangzhi Yue, Yue Suo, Jianhui Nie, Weijin Huang, Jia Li, Yuhua Li

Source: Frontiers in Immunology, Vol 14 (2023)

Subject Terms: heterologous prime-boost, ChAdTS-S, ARCoV, intramuscular, intranasal, SARS-COV-2 variants, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1142394/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/ed4ce87f1c364ac099e43b924d0726bd

Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study

Authors: Kriangkrai Tawinprai, Pawornrath Jungsomsri, Onnicha Pinijnai, Fahsiri Tavonvunchai, Anchisa Lievjaroen, Paphada Suwannaroj, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Gaidganok Sornsamdang, Teerapat Ungtrakul

Source: Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)

Subject Terms: covid-19, heterologous prime-boost, vaccine combination, chadox1 ncov-19, azd1222, coronavac, bbibp-corv, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/42c6891d29e742938839e6dc6ce95afb

A preliminary study on the effectiveness of maternal to neonatal transfer of antibodies against SARS-CoV-2 in the women vaccinated with heterologous CoronaVac–ChAdOx1

Authors: Saipin Pongsatha, Theera Tongsong, Jiraprapa Wipasa, Supachai Sakkhachornphop, Sayamon Hongjaisee, Kriangkrai Chawansuntati

Source: Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)

Subject Terms: adenoviral vector, antibodies, covid-19, heterologous prime-boost, immunogenicity, inactivated, newborn, pregnancy, sars-cov-2, spike protein, vaccine, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/7b91aaca73d14a638baedab797693328

Mixed formulation of mRNA and protein‐based COVID‐19 vaccines triggered superior neutralizing antibody responses

Authors: Jialu Zhang, Qian He, Xujia Yan, Jianyang Liu, Yu Bai, Chaoqiang An, Bopei Cui, Fan Gao, Qunying Mao, Junzhi Wang, Miao Xu, Zhenglun Liang

Source: MedComm, Vol 3, Iss 4, Pp n/a-n/a (2022)

Subject Terms: COVID‐19 vaccine, heterologous prime‐boost, neutralizing antibody, SARS‐CoV‐2, Th1 response, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/2688-2663

Access URL: https://doaj.org/article/ee9a423ddc1c4d6f935b8a6810ccf724

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines

Authors: Guy Cohen, Pawornrath Jungsomsri, Jirath Sangwongwanich, Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda

Source: Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)

Subject Terms: covid-19, heterologous prime-boost, vaccine combination, chadox1 ncov-19, azd1222, coronavac, immunogenicity, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/ace75072a2284f9c82835fe675893969

Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice

Authors: Juan Wu, Zhidong Hu, Shui-Hua Lu, Xiao-Yong Fan

Source: Frontiers in Microbiology, Vol 13 (2022)

Subject Terms: heterologous prime–boost, Bacille Calmette–Guerin, DNA vaccine, Rv2299c, Mycobacterium tuberculosis, Microbiology, QR1-502

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmicb.2022.927031/full; https://doaj.org/toc/1664-302X

Access URL: https://doaj.org/article/4f7c362c3adf43ff82ff2e854481c462

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination

Authors: Noopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah, Sakinah Muhammad-Worsham, Bo Ryoung Park, Rong Liu, Phillip Grovenstein, Bao-Zhong Wang, Sang-Moo Kang

Source: Vaccines, Vol 11, Iss 7, p 1209 (2023)

Subject Terms: influenza virus, inactivated virus vaccine, heterologous prime-boost vaccination, cross-protection, Medicine

File Description: electronic resource

Relation: https://www.mdpi.com/2076-393X/11/7/1209; https://doaj.org/toc/2076-393X

Access URL: https://doaj.org/article/31e1c05891a348caac930c57c05ae5d9

DNA priming immunization is more effective than recombinant protein vaccine in eliciting antigen-specific B cell responses

Authors: Haiying Li, Shixia Wang, Guangnan Hu, Lu Zhang, Shuying Liu, Shan Lu

Source: Emerging Microbes and Infections, Vol 10, Iss 1, Pp 833-841 (2021)

Subject Terms: HIV-1, envelope glycoprotein, DNA vaccine, protein vaccine, heterologous prime – boost, antibody, Infectious and parasitic diseases, RC109-216, Microbiology, QR1-502

File Description: electronic resource

Relation: https://doaj.org/toc/2222-1751

Access URL: https://doaj.org/article/37fb71f0382744a2bd748808276d8259

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

Authors: Qian He, Qunying Mao, Chaoqiang An, Jialu Zhang, Fan Gao, Lianlian Bian, Changgui Li, Zhenglun Liang, Miao Xu, Junzhi Wang

Source: Emerging Microbes and Infections, Vol 10, Iss 1, Pp 629-637 (2021)

Subject Terms: Heterologous prime-boost, COVID-19 vaccine, neutralizing antibody, T cell response, th1/th2 balance, Infectious and parasitic diseases, RC109-216, Microbiology, QR1-502

File Description: electronic resource

Relation: https://doaj.org/toc/2222-1751

Access URL: https://doaj.org/article/04a45915640f4c61babc730617a66e76

Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses

Authors: Sandra S. Ring, Michał Królik, Fabienne Hartmann, Erika Schmidt, Omar Hasan Ali, Burkhard Ludewig, Stefan Kochanek, Lukas Flatz

Source: Molecular Therapy: Oncolytics, Vol 19, Iss , Pp 179-187 (2020)

Subject Terms: Cancer vaccination, Viral Vectors, Melanoma, gp100, heterologous prime boost, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2372770520301522; https://doaj.org/toc/2372-7705

Access URL: https://doaj.org/article/d15d15bfa407456e9ac94b7bf1ffabca